ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169 | +4.3% | 1,810 | 0.0% | 0.01% | +16.7% |
| Q2 2023 | $162 | -16.5% | 1,810 | 0.0% | 0.01% | -7.7% |
| Q1 2023 | $194 | -37.2% | 1,810 | -28.4% | 0.01% | -35.0% |
| Q4 2022 | $309 | -99.9% | 2,528 | +26.3% | 0.02% | +42.9% |
| Q3 2022 | $207,000 | +54.5% | 2,002 | +39.2% | 0.01% | +75.0% |
| Q2 2022 | $134,000 | +415.4% | 1,438 | +550.7% | 0.01% | +700.0% |
| Q1 2022 | $26,000 | -82.6% | 221 | -80.0% | 0.00% | -85.7% |
| Q4 2021 | $149,000 | -68.0% | 1,104 | -62.2% | 0.01% | -65.0% |
| Q3 2021 | $465,000 | -13.1% | 2,920 | -28.2% | 0.02% | -4.8% |
| Q2 2021 | $535,000 | +31.1% | 4,069 | +28.7% | 0.02% | +23.5% |
| Q1 2021 | $408,000 | +4.9% | 3,162 | +35.5% | 0.02% | 0.0% |
| Q4 2020 | $389,000 | +2.9% | 2,334 | -4.8% | 0.02% | -10.5% |
| Q3 2020 | $378,000 | +13.5% | 2,451 | +9.0% | 0.02% | -9.5% |
| Q2 2020 | $333,000 | +75.3% | 2,249 | +33.0% | 0.02% | +40.0% |
| Q1 2020 | $190,000 | -23.7% | 1,691 | -5.4% | 0.02% | 0.0% |
| Q4 2019 | $249,000 | +43.1% | 1,787 | -1.3% | 0.02% | +36.4% |
| Q3 2019 | $174,000 | +10.8% | 1,810 | +32.7% | 0.01% | +22.2% |
| Q2 2019 | $157,000 | – | 1,364 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |